The Unmet Need in Cholesterol Management
Cardiovascular Diseases (CVDs) continue to be one of the leading causes of morbidity and mortality worldwide, primarily driven by underlying lipid disorders, including Hypercholesterolemia (familial and non-familial hypercholesterolemia), Dyslipidemia, Atherosclerotic Cardiovascular Disease (ASCVD), (Acute Coronary Syndrome [ACS], stroke, and coronary revascularization [CABG and PCI], etc.). Statins remain the foundation of lipid-lowering therapy, yet real-world use often falls short of guidelines. The 2021 American Heart Association (AHA) report found that only 31.9% of patients with severe hypercholesterolemia received app...
